Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Other Working Capital Changes (2018 - 2025)

TELA Bio has reported Other Working Capital Changes over the past 8 years, most recently at $153000.0 for Q4 2025.

  • Quarterly results put Other Working Capital Changes at $153000.0 for Q4 2025, down 48.48% from a year ago — trailing twelve months through Dec 2025 was -$133000.0 (up 41.41% YoY), and the annual figure for FY2025 was -$133000.0, up 41.41%.
  • Other Working Capital Changes for Q4 2025 was $153000.0 at TELA Bio, up from -$272000.0 in the prior quarter.
  • Over the last five years, Other Working Capital Changes for TELA hit a ceiling of $1.2 million in Q4 2021 and a floor of -$497000.0 in Q1 2022.
  • Median Other Working Capital Changes over the past 5 years was -$217000.0 (2023), compared with a mean of -$25150.0.
  • Biggest five-year swings in Other Working Capital Changes: plummeted 184.1% in 2022 and later surged 316.98% in 2023.
  • TELA Bio's Other Working Capital Changes stood at $1.2 million in 2021, then crashed by 90.96% to $106000.0 in 2022, then surged by 316.98% to $442000.0 in 2023, then plummeted by 32.81% to $297000.0 in 2024, then tumbled by 48.48% to $153000.0 in 2025.
  • The last three reported values for Other Working Capital Changes were $153000.0 (Q4 2025), -$272000.0 (Q3 2025), and $166000.0 (Q2 2025) per Business Quant data.